酒精性肝炎的疾病严重程度模型和新的预后见解
Vlad-Teodor Enciu1,2, Priscila Mădălina Ologeanu1,2, Ana-Maria Călin-Necula1,2
11Department of Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
概括
一个新的预后得分准确地预测酒精性肝炎 (AH) 患者的30天死亡率. 这一分数包括炎症和肝功能障碍标志物,为改善患者的治疗结果提供了改善的严重程度分层.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 有害的酒精消费是全球主要的健康风险,每年导致300多万死亡.
- 酒精性肝炎 (AH) 是一种严重的肝病,短期死亡率高,需要更好的预后工具.
- 目前AH的预后模型在准确分层个体患者的结果方面存在局限性.
研究的目的:
- 确定用于精确评估酒精性肝炎 (AH) 患者30天死亡率的新参数.
- 为管理AH的临床医生开发一个新的,可访问的严重性评分.
主要方法:
- 这是一项前性研究,涉及70名在2022-2023年期间被诊断为AH患者,但不包括那些患有严重并发症的患者.
- 临床和实验室参数在基线和第7天被评估,以30天死亡率为主要终点.
- 进行了统计分析,包括单变量和多变量回归,以确定死亡率的预测因素.
主要成果:
- 该研究确定了发烧,感染,食道静脉,前热血素时间 (PT),INR,总胆红素,CRP,LDH和CHI作为死亡率预测因素.
- 通过使用总胆红素 (7日),CRP,PT,发烧和CHI开发了一个新的预后得分,达到0.950.95的AUC.
- 新得分显示,与ABIC,GAHS和MELD-Na等非显著模型相比,新得分具有更高的歧视力,而MDF和Lille的得分表现良好.
结论:
- 结合炎症 (CRP,发烧) 和 (CHI) 标志物与肝功能障碍参数 (总 bilirubin, PT) 的新预后评分有效预测AH的30天死亡率.
- 纳入CRP提供了一个独特的优势,可能提高得分在AH严重程度分层的实用性.
- 已经确立的MDF和Lille等得分得到了验证,但新的得分为临床使用提供了潜在的更准确和更容易获得的工具.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...


